Skip to main content
Earnings Labs
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ·Healthcare·Biotechnology

$16.33

+0.74%

Mkt Cap $2.22B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (10 analysts)

$16.00

Range $16.00 – $16.00

Implied Upside

-2.0%

Consensus $16.00 vs current $16.33